Marshall Wace, LLP Avid Bioservices, Inc. Transaction History

Marshall Wace, LLP

  • $78.4 Billion
  • Q4 2024

A detailed history of Marshall Wace, LLP transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 85,600 shares of CDMO stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85,600
Previous 493,157 82.64%
Holding current value
$1.07 Million
Previous $5.61 Million 81.17%
% of portfolio
0.0%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$9.96 - $12.36 $4.06 Million - $5.04 Million
-407,557 Reduced 82.64%
85,600 $1.06 Million
Q3 2024

Nov 14, 2024
BUY
$6.7 - $12.45 $1.99 Million - $3.71 Million
297,696 Added 152.3%
493,157 $5.61 Million
Q2 2024

Aug 14, 2024
BUY
$6.34 - $9.28 $1.24 Million - $1.81 Million
195,461 New
195,461 $1.4 Million
Q4 2023

Feb 14, 2024
BUY
$4.64 - $9.56 $236,523 - $487,321
50,975 Added 25.88%
247,966 $1.61 Million
Q3 2023

Nov 14, 2023
SELL
$9.4 - $14.04 $71,280 - $106,465
-7,583 Reduced 3.71%
196,991 $1.86 Million
Q2 2023

Aug 14, 2023
SELL
$12.96 - $20.93 $891,285 - $1.44 Million
-68,772 Reduced 25.16%
204,574 $2.86 Million
Q1 2023

May 15, 2023
BUY
$13.48 - $18.79 $3.68 Million - $5.14 Million
273,346 New
273,346 $5.13 Million
Q2 2022

Aug 15, 2022
BUY
$11.63 - $21.55 $93,307 - $172,895
8,023 Added 39.17%
28,505 $435,000
Q1 2022

May 16, 2022
BUY
$16.63 - $27.73 $340,615 - $567,965
20,482 New
20,482 $416,000
Q2 2021

Aug 13, 2021
SELL
$18.93 - $25.65 $314,256 - $425,815
-16,601 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$11.86 - $21.77 $75,477 - $138,544
-6,364 Reduced 27.71%
16,601 $303,000
Q4 2020

Feb 16, 2021
BUY
$7.25 - $11.76 $166,496 - $270,068
22,965 New
22,965 $265,000
Q3 2020

Nov 16, 2020
SELL
$6.53 - $8.6 $442,133 - $582,288
-67,708 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$4.11 - $6.78 $278,279 - $459,060
67,708 New
67,708 $444,000
Q3 2019

Nov 14, 2019
SELL
$5.07 - $7.08 $1.64 Million - $2.3 Million
-324,328 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$3.43 - $5.6 $169,383 - $276,544
49,383 Added 17.96%
324,328 $1.82 Million
Q1 2019

May 14, 2019
BUY
$3.56 - $4.82 $549,639 - $744,174
154,393 Added 128.07%
274,945 $1.17 Million
Q4 2018

Feb 14, 2019
BUY
$4.04 - $6.75 $487,030 - $813,726
120,552 New
120,552 $494,000

Others Institutions Holding CDMO

# of Institutions
209
Shares Held
67.1M
Call Options Held
216K
Put Options Held
4.6K
View Full List

About Avid Bioservices, Inc.

CDMO Quotes by TradingView
  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email